Series Feature: “Internationalization”
Enhancing Japan’s Global Presence
With the establishment of international cooperation frameworks such as APAC and ICH, efforts toward regulatory harmonization and improved access to medicines in the global and Asian regions are accelerating. International collaboration within the pharmaceutical industry is advancing to deliver medicines to patients around the world.
From JPMA
A New Era Pioneered by Global Collaboration
The Essentials of International Cooperation as Envisioned by the JPMA
The theme of this issue is “Internationalization.” Mr. Nakagawa, Executive Director of the JPMA, spoke passionately about the future vision for internationalization—including the promotion of regulatory harmonization and the establishment of cooperative frameworks with the Asian region—as well as the approach to international collaboration that leverages Japan’s strengths.
My Committee
Vol. 2 International Affairs Committee
The JPMA comprises 12 committees and six specialized organizations. In this second installment, we focus on the International Affairs Committee. It operates under a three-subcommittee structure: the Europe and U.S. Subcommittee, the Asia Subcommittee, and the Global Health Subcommittee. We bring you firsthand accounts from committee members regarding their activities in various countries and regions across Europe, the U.S., and Asia.
Topics
Introducing Various Topics from Within the Association
We bring you the latest developments, including the release of “Industry Vision 2035,” a conference aimed at building an ecosystem for infectious disease drug discovery, efforts to eradicate NTDs (neglected tropical diseases) that bring together next-generation ideas, and new challenges facing intellectual property professionals.
＼Please click here to share your feedback on our redesigned newsletter.／